Mamta Jain

Has grant

Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mamta Jain is a Professor at UT Southwestern Medical Center in the United States. Her research focuses on infectious diseases, particularly HIV/AIDS, hepatitis B and C, and the impact of treatments on viral infections. Recent publications include studies on the implications of health policies, such as the Ryan White HIV/AIDS Program, as well as the effects of various treatments on biomarker trajectories in COVID-19 patients.

Recent Grants

Grant: Close

STOP-HCC Expansion Grant

Open Date: 2018-08-24

Close Date:

Grant: Close

Evidence-Based Hepatocellular Cancer Prevention through Targeted Hepatitis C Screening and Navigation

Open Date: 2018-02-21

Close Date:

Grant: Close

U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT

Open Date: 2000-01-01

Close Date: 2008-12-31

Grant: Close

GENERAL CLINICAL RESEARCH CENTER

Open Date: 1978-12-01

Close Date: 2007-09-16

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

Daniel Duprez

Professor of Medicine/Cardiology

University of Minnesota

UNITED STATES

Mamta Jain

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

The Potential Impact of Ending the Ryan White HIV/AIDS Program on HIV Incidence: A Simulation Study in 31 U.S. Cities

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?

Who Is at Risk for New Hepatitis B Infections Among People With HIV?

Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort

Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Educating Primary Care Providers and Associate Care Providers About Hepatitis C Screening of Baby Boomers: a Multi-practice Study

A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection

Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

Low Rates of Hepatitis B Virus Treatment among Treatment-Eligible Patients in Safety-Net Health Systems

Collaborators (17)

Daniel Duprez

Christian T. Brandt

Alejandro Arenas-Pinto

John Beigel

Barbara J Turner

Sean Callahan

Sean Liu

Hillary Vanderven

Sandra Safo

Timothy Hatlen

Kirby Mayer

Shijing Jia

Joyce Jones

Mark Polizzotto

Olivia Krol

Stuart Turville

Brian Angus

Make your next move.